Noida, India

Sanjeev Soni

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Greater Noida, IN (2020 - 2022)
  • Noida, IN (2021 - 2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sanjeev Soni: Innovator in Oncology Therapeutics

Introduction

Sanjeev Soni is a prominent inventor based in Noida, India. He has made significant contributions to the field of oncology through his innovative research and development of therapeutic agents. With a total of four patents to his name, Soni is recognized for his work in creating compounds that target critical pathways in cancer treatment.

Latest Patents

Soni's latest patents include "Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors." This invention provides substituted pyrazolo[3,4-d]pyrimidine compounds that serve as Wee1 inhibitors. These compounds may be utilized as therapeutic agents for treating various diseases, particularly in oncology. Another notable patent is "Heterocyclic compounds and uses thereof," which also focuses on heterocyclic compounds as Wee1 inhibitors. These compounds are designed to be therapeutic agents for disease treatment, with a specific emphasis on oncology applications.

Career Highlights

Sanjeev Soni is currently associated with Nuvation Bio Inc., where he continues to advance his research in the field of oncology. His work has been instrumental in developing new therapeutic strategies that could potentially improve patient outcomes in cancer treatment.

Collaborations

Soni collaborates with talented individuals in his field, including Sarvajit Chakravarty and Son Minh Pham. These collaborations enhance the innovative potential of his research and contribute to the development of effective therapeutic agents.

Conclusion

Sanjeev Soni is a dedicated inventor whose work in oncology is paving the way for new therapeutic options. His patents reflect a commitment to advancing medical science and improving treatment methodologies for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…